Biogen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Biogen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Contact:Cambridge, MA, - - Biogen Inc. (Nasdaq: BIIB) announced today that Christopher A. Viehbacher, President and Chief Executive Officer, will present during the 43rd Annual J.P. Morgan Healthcare Conference. The webcast will be live on Tuesday, January 14, 2024, at 12:45 p.m. ET. To access the live webcast, please visit the Investors section of Biogen's website at investors.biogen.com. An archived version of the webcast will be available for at least 30 days following the presentation.
马萨诸塞州剑桥 - 渤健公司（纳斯达克：BIIB）今天宣布，首席执行官克里斯托弗·A·维赫巴赫将在第43届年度摩根大通医疗会议上进行演讲。网络直播将于2024年1月14日星期二下午12:45（东部时间）进行。要访问网络直播，请访问渤健公司网站的投资者部分，网址为 investors.biogen.com。直播的存档版本将在演讲后至少提供30天。
About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
关于渤健公司
渤健公司成立于1978年，是一家领先的生物技术公司，开创创新科学，提供新药来改变患者的生活，并为股东和社区创造价值。我们运用对人类生物学的深刻理解，利用不同的手段推进首创的治疗方法或疗法，以提供更卓越的疗效。我们的做法是承担大胆的风险，同时平衡投资回报，以实现长期增长。
We routinely post information that may be important to investors on our website at . Follow us on social media - Facebook, LinkedIn, X, YouTube.
我们定期在我们的网站上发布可能对投资者重要的信息。请在社交媒体上关注我们 - Facebook、LinkedIn、X、YouTube。
Contact:
联系：
Karen Jewell
Investor Relations
Biogen
781.464.2442
卡伦·朱尔
投资者关系
Biogen
781.464.2442
